Acknowledgement
Supported by : KHIDI, NRF
References
- Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2014;384:766-781. https://doi.org/10.1016/S0140-6736(14)60460-8
- Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J 2014;26:20-24.
- Grand View Research. Obesity treatment market size & forecast, by drugs (combination drugs, appetite suppressants, malabsorption & satiety drugs), by surgery & devices (adjustable gastric banding, Rouxen-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion with duodenal switch, endoscopic procedures) and trend analysis to 2024 [Internet]. San Francisco (CA): Grand View Research; c2016 [updated 2016 Sep; cited 2018 Sep 20]. Available from: https://www.grandviewresearch.com/industry-analysis/obesity-treatment-devices-and-therapeutics-market.
- Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes 2013;20:377-388. https://doi.org/10.1097/01.med.0000433067.01671.f5
- Nguyen NT, Vu S, Kim E, Bodunova N, Phelan MJ. Trends in utilization of bariatric surgery, 2009-2012. Surg Endosc 2016;30:2723-2727. https://doi.org/10.1007/s00464-015-4535-9
- Vargas EJ, Rizk M, Bazerbachi F, Abu Dayyeh BK. Medical devices for obesity treatment: endoscopic bariatric therapies. Med Clin North Am 2018;102:149-163. https://doi.org/10.1016/j.mcna.2017.08.013
- Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology 2017;152:1791-1801. https://doi.org/10.1053/j.gastro.2017.01.044
- Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT. Current status of intragastric balloon for obesity treatment. World J Gastroenterol 2016;22:5495-5504. https://doi.org/10.3748/wjg.v22.i24.5495
- Gleysteen JJ. A history of intragastric balloons. Surg Obes Relat Dis 2016;12:430-435. https://doi.org/10.1016/j.soard.2015.10.074
- Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982;1:198-199.
- Gomez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study. Obesity (Silver Spring) 2016;24:1849-1853. https://doi.org/10.1002/oby.21555
- Swidnicka-Siergiejko A, Wroblewski E, Andrzej D. Endoscopic treatment of obesity. Can J Gastroenterol 2011;25:627-633. https://doi.org/10.1155/2011/174163
- Kentish SJ, Page AJ. The role of gastrointestinal vagal afferent fibres in obesity. J Physiol 2015;593:775-786. https://doi.org/10.1113/jphysiol.2014.278226
- Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg 2014;24:813-819. https://doi.org/10.1007/s11695-014-1176-3
- Machytka E, Gaur S, Chuttani R, et al. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy 2017;49:154-160.
-
Lecumberri E, Krekshi W, Matia P, et al. Effectiveness and safety of airfilled balloon Heliosphere
$BAG^{(R)}$ in 82 consecutive obese patients. Obes Surg 2011;21:1508-1512. https://doi.org/10.1007/s11695-010-0314-9 - Almeghaiseeb ES, Ashraf MF, Alamro RA, Almasoud AO, Alrobayan AA. Efficacy of intragastric balloon on weight reduction: Saudi perspective. World J Clin Cases 2017;5:140-147. https://doi.org/10.12998/wjcc.v5.i4.140
- Zurawinski W, Sokolowski D, Krupa-Kotara K, Czech E, Sosada K. Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method. Wideochir Inne Tech Maloinwazyjne 2017;12:37-48.
- Keren D, Rainis T. Intragastric balloons for overweight populations-1 year post removal. Obes Surg 2018;28:2368-2373. https://doi.org/10.1007/s11695-018-3167-2
- Gaggiotti G, Tack J, Garrido AB Jr, Palau M, Cappelluti G, Di Matteo F. Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey. Obes Surg 2007;17:949-956. https://doi.org/10.1007/s11695-007-9174-3
- Carvalho GL, Barros CB, Okazaki M, et al. An improved intragastric balloon procedure using a new balloon: preliminary analysis of safety and efficiency. Obes Surg 2009;19:237-242. https://doi.org/10.1007/s11695-008-9592-x
- Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity. J Clin Gastroenterol 2008;42:48-53. https://doi.org/10.1097/01.mcg.0000247992.89215.88
- Martin CK, Bellanger DE, Rau KK, Coulon S, Greenway FL. Safety of the Ullorex oral intragastric balloon for the treatment of obesity. J Diabetes Sci Technol 2007;1:574-581. https://doi.org/10.1177/193229680700100416
- Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015;11:874-881. https://doi.org/10.1016/j.soard.2014.12.006
-
US Food and Drug Administration. Summary of safety and effectiveness data (SSED):
$ORBERA^{TM}$ intragastric balloon system [Internet]. Silver Spring (MD): FDA; c2015 [updated 2015 Aug 5; cited 2018 Sep 20]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140008b.pdf. - US Food and Drug Administration. Summary of safety and effectiveness data (SSED): Obalon balloon system [Internet]. Silver Spring (MD): FDA; c2016 [updated 2016 Sep 8; cited 2018 Sep 20]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160001b.pdf.
- Borges AC, Almeida PC, Furlani SMT, Cury MS, Gaur S. Intragastric balloons in high-risk obese patients in a Brazilian center: initial experience. Rev Col Bras Cir 2018;45:e1448.
- Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg 2011;21:1499-1507. https://doi.org/10.1007/s11695-011-0424-z
- Russo T, Aprea G, Formisano C, et al. BioEnterics intragastric balloon (BIB) versus spatz adjustable balloon system (ABS): our experience in the elderly. Int J Surg 2017;38:138-140. https://doi.org/10.1016/j.ijsu.2016.06.013
- Daniel F, Abou Fadel C, Houmani Z, Salti N. Spatz 3 adjustable intragastric balloon: long-term safety concerns. Obes Surg 2016;26:159-160. https://doi.org/10.1007/s11695-015-1897-y
- Bazerbachi F, Vargas Valls EJ, Abu Dayyeh BK. Recent clinical results of endoscopic bariatric therapies as an obesity intervention. Clin Endosc 2017;50:42-50. https://doi.org/10.5946/ce.2017.013
- Alsabah S, Al Haddad E, Ekrouf S, Almulla A, Al-Subaie S, Al Kendari M. The safety and efficacy of the procedureless intragastric balloon. Surg Obes Relat Dis 2018;14:311-317. https://doi.org/10.1016/j.soard.2017.12.001
- Angrisani L, Santonicola A, Vitiello A, Belfiore MP, Belfiore G, Iovino P. Elipse balloon: the pitfalls of excessive simplicity. Obes Surg 2018;28:1419-1421. https://doi.org/10.1007/s11695-018-3148-5
- Trande P, Mussetto A, Mirante VG, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg 2010;20:1227-1230. https://doi.org/10.1007/s11695-008-9786-2
- Caglar E, Dobrucali A, Bal K. Gastric balloon to treat obesity: filled with air or fluid? Dig Endosc 2013;25:502-507. https://doi.org/10.1111/den.12021
- De Castro ML, Morales MJ, Del Campo V, et al. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg 2010;20:1642-1646. https://doi.org/10.1007/s11695-010-0128-9
- Giardiello C, Borrelli A, Silvestri E, Antognozzi V, Iodice G, Lorenzo M. Air-filled vs water-filled intragastric balloon: a prospective randomized study. Obes Surg 2012;22:1916-1919. https://doi.org/10.1007/s11695-012-0786-x
- Drozdowski R, Wyle?ol M, Fr?czek M, Hevelke P, Giaro M, Sobanski P. Small bowel necrosis as a consequence of spontaneous deflation and migration of an air-filled intragastric balloon - a potentially life-threatening complication. Wideochir Inne Tech Maloinwazyjne 2014;9:292-296.
- Buzga M, Evzen M, Pavel K, et al. Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance. Obes Surg 2014;24:909-915. https://doi.org/10.1007/s11695-014-1191-4
-
Buzga M, Kupka T, Siroky M, et al. Short-term outcomes of the new intragastric balloon End-
$Ball^{(R)}$ for treatment of obesity. Wideochir Inne Tech Maloinwazyjne 2016;11:229-235. - Pezzo CT, de Souza TF, Fenero V, Suano-Souza FI, Grecco E, Sarni ROS. Efficacy and safety of intragastric balloon in the treatment of obesity in adolescent females. Nutrire 2017;42:26. https://doi.org/10.1186/s41110-017-0052-z
- Neto MG, Silva LB, Grecco E, et al. Brazilian intragastric balloon consensus statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis 2018;14:151-159. https://doi.org/10.1016/j.soard.2017.09.528
- Do TN, Ho KY, Phee SJ. A magnetic soft endoscopic capsule-inflated intragastric balloon for weight management. Sci Rep 2016;6:39486. https://doi.org/10.1038/srep39486
- Ghoz HM, Acosta A, Topazian M, Camilleri M, Gostout C, Dayyeh BKA. A pre-clinical animal study of combined intragastric balloon and duodenal-jejunal bypass sleeve for obesity and metabolic disease. Gastroenterology 2016;150(4 Suppl 1):S231-S232.
- Choi HS, Chun HJ. Recent trends in endoscopic bariatric therapies. Clin Endosc 2017;50:11-16. https://doi.org/10.5946/ce.2017.007
Cited by
- Endoscopic Bariatric Therapy: A Guide to the Intragastric Balloon vol.114, pp.9, 2018, https://doi.org/10.14309/ajg.0000000000000239
- Ingestible Sensors and Sensing Systems for Minimally Invasive Diagnosis and Monitoring: The Next Frontier in Minimally Invasive Screening vol.5, pp.4, 2018, https://doi.org/10.1021/acssensors.9b02263
- The Efficacy and Safety of a Procedureless Gastric Balloon for Weight Loss: a Systematic Review and Meta-Analysis vol.30, pp.9, 2018, https://doi.org/10.1007/s11695-020-04522-3
- Endobariatric procedures for obesity: clinical indications and available options vol.14, pp.None, 2021, https://doi.org/10.1177/2631774520984627
- The Clinical and Metabolic Effects of Intragastric Balloon on Morbid Obesity and Its Related Comorbidities vol.54, pp.1, 2018, https://doi.org/10.5946/ce.2020.302
- A Randomized, Controlled Trial Comparing the Impact of a Low-Calorie Ketogenic vs a Standard Low-Calorie Diet on Fat-Free Mass in Patients Receiving an Elipse™ Intragastric Balloon Treatment vol.31, pp.4, 2018, https://doi.org/10.1007/s11695-020-05133-8
- Endoscopic intragastric balloon therapy for 15 years in Japan: Results of nationwide surveys vol.14, pp.3, 2018, https://doi.org/10.1111/ases.12881
- Effects of intragastric balloon on obesity in obese Korean women for 6 months post removal vol.15, pp.4, 2021, https://doi.org/10.4162/nrp.2021.15.4.456
- Six intragastric balloons: Which to choose? vol.13, pp.8, 2018, https://doi.org/10.4253/wjge.v13.i8.238